JerMa88/BMC_Womens_Health_Peer_Reviews huggingface dataset:
Title: Candidiasis profile at the Outpatient Department of the University of Cape Coast hospital
in the Central region of Ghana: A retrospective study
Version: 9 Date: 25 Feb 2023
Reviewer's report:
The authors have addressed all issues raised in my previous comments. The manuscripts is now
ready for publication.
Authors should however address the issue before before acceptance.
1. The x-axis in all the graphs in figure 3  is labeled "Age category/yr. Authors should remove
the " yr" attached to the age groups as that's already represented in the axis label. Authors should
also revise " yr" to " year"
2. Authors should provide a label (Year) for the x-axis in all the graphs in figure 4.
Title: Implications of Serum Uric Acid for Female Infertility: Results from the National Health
and Nutrition Examination Survey, 2013–2020
Version: 1 Date: 08 Dec 2022
Reviewer:  Antoine Naem
Reviewer's report:
General impression:
The authors conducted an interesting study to investigate the correlation between serum uric
acid levels and infertility. The study included a large cohort but relies on secondary analysis
of prospectively-collected self-reported data. I believe the strengths of this study extremely
overweight the limitations and highlight a significant but weak correlation between fertility and
serum uric acid levels. I think this paper should be revised to improve its quality.
Comments:
1. In the Methods section of the abstract, lines 15 to 18 carry the same meaning, please rephrase
by avoiding the redundancy.
2. In the Background section (line 32), I would suggest writing (regular and unprotected
intercourse) and adding (the duration is shortened to 6 months in patients older than 35 years
old). This will make the definition comprehensive and precise.
3. In the background section, lines 42 and 43 are redundant. You can alternatively write “which
has been identified to affect multiple body organs through multiple pathways”.
4. In the methods section (line 71), please write the full term of the abbreviation “NHANES”
before its first use in the main text.
5. In the methods section (line 72), could you please explain what does “cycles” refer to? I.e.,
which patient populations were included in the NHANES survey (fertile and infertile or only
infertile). Also, did you mean “years” instead of “cycles”?
6. In the methods section (line 94), could you please explain how you allocated patients to
the “fertile” group? Obviously, responding no to this question does not mean she is fertile.
Therefore, there should be more detailed criteria to consider a woman fertile.
7. In the methods section, please highlight whether you collected data on concomitant
gynaecological diseases (like endometriosis, PCOS, fibroids, polyps, etc…). If so, please
indicate whether you adjusted your analysis for these factors or whether you excluded the
patients.
8. In the methods section (line 139), please clarify what you refer to by “the fully adjusted
model”, did you adjust for all the aforementioned factors in models 1 to 3 in model 4? If yes,
please write that explicitly.
9. In the results section (line 159), could you please clarify the meaning (have ever been
pregnant)? Is it “have never been pregnant” or “have been pregnant at least once”?
10. Based on the previous comment, please mention that you included patients with primary
and secondary infertility.
11. Please revise the written language because it contains many grammatical and linguistic
mistakes.
Title: Implications of Serum Uric Acid for Female Infertility: Results from the National Health
and Nutrition Examination Survey, 2013–2020
Version: 1 Date: 15 Dec 2022
Reviewer's report:
1. Abstract
The background does not show the rationale for this research. I suggest the authors highlight
how serum uric acid can be related to infertility.
2. Introduction
The authors should highlight more about the rationale of this topic. They should stress the
possible pathophysiology which may lead to infertility.
Title: Implications of Serum Uric Acid for Female Infertility: Results from the National Health
and Nutrition Examination Survey, 2013–2020
Version: 4 Date: 18 Feb 2023
Reviewer:  Antoine Naem
Reviewer's report:
Dear Authors,
Thank you for addressing my previous comments. I confirm that the manuscript was
significantly improved and it is suitable for publication. I have no further comments.
With kind regards,
Title: Identification of age differences in cancer-related symptoms in women undergoing
chemotherapy for breast cancer in China
Version: 1 Date: 11 Jan 2023
Reviewer's report:
This manuscript presents novel approaches to identifying age-related differences in symptom
severity experienced by women undergoing treatment for chemotherapy. The focus of age-group
comparisons is young (18 to <40), middle age (40 to <60) and older women (60+). The study
is a single-survey cross-sectional design.
This manuscript adds to the rapidly-growing literature pertaining to patient-reported symptoms
during cancer treatment and the value of helping clinicians identify/monitor patients at high risk
for symptom severity and interference with daily living.
What is unique within the current literature is this manuscript’s use of (1) network analysis to
graphically illustrate what is already well-known about the inter-relatedness of symptoms and
(2) latent class analysis to refine where interventions should be targeted. The explanation of
network analysis results was especially helpful and well-written, less so the LCA results (see
below).
Limitation: Stage and phenotype of BC are not stated or compared among age groups. If the
sample includes women with Stage IV BC, that complicates the analyses. Even without Stage
IV patients, the differences among age groups with regard to BC stage and phenotype are central
to the story line of age-related treatment toxicities.
Limitation: Specific chemotherapy drugs (e.g., anthracycline-based, paclitaxel) and regimens
(e.g., AC-T, AC-TC, TC, TCH, other) are not stated or compared.  (1) These specifics relate to
BC stage and phenotype within each age group. It is not enough to just state that BC tumors tend
to be more severe in younger women. (2) The toxicity profiles of specific drugs and regimens
varies greatly – see numerous Nyrop KA articles starting in 2019. The identification of specific
sub-groups within each age group will be greatly influenced by their specific treatment regimen.
Suggestion: As an appendix, it would be interesting to see a descriptive summary of all items
included in the data base (total sample and comparison of age groups), especially the results from
PROMIS -57 and PROMIS-cognitive function, annotated with clinically significant cut points.
Suggestion: Figure 1 is not needed because all of the essential information is already in Table 2.
Suggestion: In the LCA results and Table 3, please describe AIC, BIC and aBIC and what it
means that they are “relatively low”. Also, LMR and BLRT. Also, how to understand the latent
class probability results, to make all of this more usable to clinicians who may not be familiar
with LCA.
Suggestion: Table 4 and related paragraphs do not add much to what has already been presented
– could be deleted if there is a need to shorten the manuscript or reduce the number of tables.
Edit: In Figure 2, correct the spelling for depression
Title: Identification of age differences in cancer-related symptoms in women undergoing
chemotherapy for breast cancer in China
Version: 1 Date: 17 Jan 2023
Reviewer:  Thais De Oliveira Gozzo
Reviewer's report:
Methods-
I suggest excluding "did not want to participate" from the exclusion criteria, as this is a research
participant's right.
Doubt: If one of the goals was to assess symptoms during chemotherapy, could women be
included in any treatment cycle? This is not specified in the inclusion criteria and there is a
difference in the occurrence of symptoms between those who are in the first and those who are
in the last cycle of chemotherapy
Doubt: were 40 year were include: young-aged group (younger than 40 years) OR middle-aged
group (between 40 and 59 years)?
What was considered as complications?
Which chemotherapy protocols were included?
Is chemoradiation not too distinct from IV chemotherapy in drugs, dosage, number of cycles,
etc, to be compare?
Title: Identification of age differences in cancer-related symptoms in women undergoing
chemotherapy for breast cancer in China
Version: 2 Date: 02 Mar 2023
Reviewer:  Thais De Oliveira Gozzo
Reviewer's report:
I believe that the additions made to the text, as well as the clarifications, were adequate and
sufficient to clarify what was pointed out in the opinion.
Congratulations to the authors for addressing relevant issues for women's care during
chemotherapy.
Title: A cross-sectional study of knowledge, attitudes, barriers and practices of cervical cancer
screening among nurses in selected hospitals in the Eastern Cape Province, South Africa
Version: 1 Date: 06 Dec 2022
Reviewer's report:
Thank you for providing me with the opportunity for reviewing this interesting manuscript. I
have only a few minor comments that must be taken into account, they may improve the quality
of the manuscript.
In the background need to highlight important of patient safety and how these concept affect
nurses work.  Kindly use this articles.
• Patient safety attitudes among critical care nurses: A case study in North Cyprus.
• Patient Safety Attitudes among Doctors and Nurses: Associations with Workload, Adverse
Events, Experience.
Discussion and conclusion
Briefly comment on why the study is necessary without repeating the sentences used in the
introduction, and include the important of nursing education to improve nurse’s knowledge.
Kindly use this articles.
• Effectiveness of a venous thromboembolism course using flipped classroom with nursing
students: A randomized controlled trial.
Summary of key findings (primary outcome measures, secondary outcome measures, results as
they relate to a prior hypothesis); compare with findings from other studies.
• Effectiveness of flipped classroom among nursing students on venous thromboembolism
(VTE)
Title: Patterns and correlates of post-abortion complications in India
Version: 1 Date: 14 Feb 2023
Reviewer's report:
"PEER REVIEWER ASSESSMENTS:
OBJECTIVE - Full research articles: is there a clear objective that addresses a testable research
question(s) (brief or other article types: is there a clear objective)?
Yes - there is a clear objective
DESIGN - Is the current approach (including controls and analysis protocols) appropriate for
the objective?
Yes - the approach is appropriate
EXECUTION - Are the experiments and analyses performed with technical rigor to allow
confidence in the results?
Yes - experiments and analyses were performed appropriately
STATISTICS - Is the use of statistics in the manuscript appropriate?
Yes - appropriate statistical analyses have been used in the study
INTERPRETATION - Is the current interpretation/discussion of the results reasonable and not
overstated?
Yes - the author's interpretation is reasonable
OVERALL MANUSCRIPT POTENTIAL - Is the current version of this work technically
sound? If not, can revisions be made to make the work technically sound?
Yes - current version is technically sound
PEER REVIEWER COMMENTS:
GENERAL COMMENTS: This is a well written study that examined the correlates of post
abortion complications in India. The study adds useful data and sound recommendations.
The authors did well by including a large sample size, and interpretation of results was sound
providing conclusion that could impact interventions in policies and programs that emphasize
offering quality abortion care.
- The study meet criteria for best practice.
- The study provided prevalence of post-abortion complications in a specific setting (India) and
identified variables of abortion complications which included gestational age of 9-20 weeks and
cause abortion (life risk/medical reasons).
- No novel findings but contributes to the existing literature.
- Allows for better understanding of risk of abortion complications in Leo resource setting and
suggest strategies for improvement.
-  Could impact interventions in policies and programs that emphasize offering quality abortion
care."
Title: Patterns and correlates of post-abortion complications in India
Version: 1 Date: 14 Feb 2023
Reviewer:  Elias Yadeta Debele
Reviewer's report:
The article is well written and organized. The authors also come up with significant research
findings. Here are some of my concerns to your consideration:
1.  In the Title: The title is too short. I hope the authors addressed two objectives in this study
so that both objectives has to be reflected in the title.
2. In the abstract: even though the authors used secondary data the study design you employed
and the approach/way the authors accessed this secondary data should be mentioned.  And it is
better if you avoid usage of abbreviation in abstract. For example SE
3. Again in the abstract the authors mentioned that Binary logistic regression was used to check
the adjusted association of socioeconomic and demographic characteristics. Better if you replace
Binary logistic regression with multivariable logistic regression. The authors also stated that
women with gestational age of 9- 20 weeks had higher odds of abortion complication. Here my
question is to classify gestational age in this way what is your rational?
4. In conclusion: you missed the recommendation. Please add the recommendation as per you
findings.
5. May main concern is how the outcome variable was measured. I think the authors used only
a single question with yes or no response (Did you have any complication from the abortion?)
to measure the outcome variable. The term complication is too broad and the participants may
not understood equally. Why the authors did not use the list of the complications to measure
the outcome variables.
6. Statistical analysis. Look at some terms like Bivariate and binary logistic regression and
correct accordingly. And also you missed the important thing here that is how was the data are
processed and handled? It has to be mentioned boldly.
7. Result section. It is fine. However, in many parts the authors preferred using narrating the
frequency. For instance rather than saying forty three percent it is better if you put 43% in
numbers.
8. Under the result: Table 3: Adjusted odds ratio (AOR) for abortion complications for women
aged 15-49, India, 2019-21. Has to be rearranged. Where is crude odd ratio, where is crosstab
frequencies for each variables. This all things has to be displayed weel in regression table. Look
at the table below
Characteristics  Complication of abortion  COR with CI AOR with CI
Yes  No
Age
15-24
24-34
9. Discussion. Is so good. Better if you reason out if your findings is dis agree with other findings.
For instance, However, an earlier study revealed that post abortion hemorrhage or fever risk
does not significantly differ at gestational age < 10 weeks and # ten weeks. But you didn’t put
the reason why the earlier study and your finding is disagree.
Title: Patterns and correlates of post-abortion complications in India
Version: 2 Date: 02 Mar 2023
Reviewer's report:
"PEER REVIEWER ASSESSMENTS:
OBJECTIVE - Full research articles: is there a clear objective that addresses one or several
testable research questions? (Brief or other article types: is there a clear objective?)
Yes - there is a clear objective
DESIGN - Is the current approach (including controls and analysis protocols) appropriate for
the objective?
Yes - the approach is appropriate
EXECUTION - Are the experiments and analyses performed with sufficient technical rigor to
allow confidence in the results?
Yes - experiments and analyses were performed appropriately
STATISTICS - Is the use of statistics in the manuscript appropriate?
Yes - appropriate statistical analyses have been used in the study
INTERPRETATION - Is the current interpretation/discussion of the results reasonable and not
overstated?
Yes - the author's interpretation is reasonable
OVERALL MANUSCRIPT POTENTIAL - Has the author addressed your concerns sufficiently
for you to now recommend the work as a technically sound contribution? If not, can further
revisions be made to make the work technically sound?
Yes - current version is technically sound
PEER REVIEWER COMMENTS:
GENERAL COMMENTS: - The authors responded adequately to each of the questions and
concerns raised by reviewers' comments
- The authors have made necessary changes in the manuscript
- Manuscript in the current version adds to the existing literature and suitable for publication.
ADDITIONAL REQUESTS/SUGGESTIONS:
- Please define abbreviations below each table"
Title: PREVALENCE, INDICATIONS AND FETAL OUTCOME OF OPERATIVE
VAGINAL DELIVERY IN SUB-SAHARAN AFRICA, SYSTEMATIC REVIEW, AND
META-ANALYSIS
Version: 3 Date: 01 Oct 2022
Reviewer's report:
I read with great interest the manuscript, which falls within the aim of this Journal. In my honest
opinion, the topic is interesting enough to attract the readers’ attention. Nevertheless, the authors
should clarify some points and improve the discussion, as suggested below.
Authors should consider the following recommendations:
- Manuscript should be further revised in order to correct some typos and improve style.
- I recommend to add further details to discuss the perineum  protection techinques and the
role of selective use of episiotomy (authors may refer to: PMID: 31823037; PMID: 25920305;
PMID: 25909491)
Title: PREVALENCE, INDICATIONS AND FETAL OUTCOME OF OPERATIVE
VAGINAL DELIVERY IN SUB-SAHARAN AFRICA, SYSTEMATIC REVIEW, AND
META-ANALYSIS
Version: 3 Date: 22 Oct 2022
Reviewer:  Sampson Opoku Agyemang
Reviewer's report:
I enjoyed reading your work. There are few suggestions I think may help improve the manuscript.
Thank you
Topic
is the work a systematic review or a meta-analysis? Kindly be specific
Introduction
“In sub-Saharan Africa, there is no recent and adequate data to show the overall magnitude of
OVD, its indications, and fetal outcomes, despite the procedure being widely done.” Provide
some studies in Africa to support your claim.
Discussion
The discussion can generally be improved. Provide adequate reasons or justifications for
similarities in your review and other studies.
Conclusion
“The overall prevalence of OVD in sub-Saharan Africa was somewhat higher compared to other
countries”. You seem not to be sure of your conclusion. Is the prevalence of OVD in sub-Saharan
Africa higher compared to other countries or not?
Title: PREVALENCE, INDICATIONS AND FETAL OUTCOME OF OPERATIVE
VAGINAL DELIVERY IN SUB-SAHARAN AFRICA, SYSTEMATIC REVIEW, AND
META-ANALYSIS
Version: 3 Date: 19 Nov 2022
Reviewer:  Ban Hadi Hameed
Reviewer's report:
dear authors thanks for your work
Abstract:
Follow journal instructions for words number
Language editing is required
The conclusion should be revised
Avoid repetition of data
References [8-12] to be appropriately cited in the introduction
Mention the aim in the introduction
Method needs abbreviation
Results: remove the sentences related to the method, poor instead of pure maternal efforts
Discussion: avoid repeating your results, fresh newborn ??
Conclusion: PSSOL repeated
references: to be revised as journal instructions
17 studies were included in the meta-analysis, figure 2 has only 10.
The total number of cases included in the meta-analysis should be clarified, as the prevalence
from the total admissions or attending the hospitals??  and also the number of cases in each
study included
Title: PREVALENCE, INDICATIONS AND FETAL OUTCOME OF OPERATIVE
VAGINAL DELIVERY IN SUB-SAHARAN AFRICA, SYSTEMATIC REVIEW, AND
META-ANALYSIS
Version: 6 Date: 15 Dec 2022
Reviewer's report:
I read with great interest the manuscript, which falls within the aim of this Journal. In my honest
opinion, the topic is interesting enough to attract the readers’ attention. Nevertheless, the authors
should clarify some points and improve the discussion, as suggested below.
Authors should consider the following recommendations:
- Manuscript should be further revised in order to correct some typos and improve style.
- I suggest to discuss, at least briefly, the use of selective episiotomy for the prevention of severe
genital lacerations in case of indication during the second phase of labour (authors may refer to:
PMID: 31823037; PMID: 25920305).
- I recommend to highlight how organization of the delivery room and potential understaffing
may significantly affect the possibility to adopt one-to-one midwifery assistance and  influence
the obstetric outcomes during delivery (authors may refer to: PMID: 27924674; PMID:
32307556).
Title: PREVALENCE, INDICATIONS AND FETAL OUTCOME OF OPERATIVE
VAGINAL DELIVERY IN SUB-SAHARAN AFRICA, SYSTEMATIC REVIEW, AND
META-ANALYSIS
Version: 6 Date: 04 Jan 2023
Reviewer:  Sampson Opoku Agyemang
Reviewer's report:
Thank you for the opportunity to review this manuscript. I do not have any comment for the
authors
Title: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-
analysis
Version: 2 Date: 07 Aug 2022
Reviewer's report:
This is an important model about the clinical and financial consequences of using the Aptima
mRNA assay for cervical screening in Portugal in comparison with hc2 + HPV genotyping or
Cobas 4800. The  model seems to be quite conclusive but there are several aspects that require
revision:
In the Abstract, Conclusion: "These values result from the greater SPECIFICITY of Aptima"
not "sensitivity".
In the Background section please mention the manufacturers of all tests. Since the whole study
is funded by Hologic, it is of major importance for the reader to understand that this is the
manufacturer of the Aptima test.
In the Background section please give some more information about the Portuguese cervical
cancer screening system: At what age is HPV testing offered? What are the screening intervals
for HPV and cytology screening?
Model inputs: Did you consider different HPV prevalence rate amoung different age groups?
What about HPV vaccination? Was that influence considered for younger women?
Discussion or Introduction: Despite all the good results from your model it has to be mentioned
that the data basis for the performance of the different HPV assays in cervical cancer screening
is much more robust for hc2 and also (to a lesser extent) for Cobas compared to Aptima.